Thrombin inhibits apoptosis of monocytes and plasminogen activator inhibitor 2 (PAI-2) is not responsible for this inhibition

Experimental Cell Research

Volumn 260, Issue 1, 2000, Pages 20-29

  Ritchie, Helen ^a   Fragoyannis, Alex ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Apoptosis; Caspase; Monocyte; PAI 2; Serpin; Thrombin

Indexed keywords

CASPASE; CASPASE 3; CASPASE 8; OVALBUMIN; PLASMINOGEN ACTIVATOR INHIBITOR 2; RECOMBINANT PLASMINOGEN ACTIVATOR; SERINE PROTEINASE INHIBITOR; THROMBIN;

APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION;

EID: 0034633888     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4957     Document Type: Article

References (42)

1. The ovalbumin family of serpin proteins
2. Thrombin modulates synthesis of plasminogen activator inhibitor 2 (PAI-2) by human peripheral blood monocytes
3. Increased release of plasminogen activator inhibitor type 2 accompanies the human mononuclear tissue factor response to lipopolysaccharide
4. Biological and clinical aspects of plasminogen activator inhibitor type 2
5. Protection from tumor necrosis-factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2
6. Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor α-induced apoptosis
7. Plasminogen activator inhibitor type 2 prevents programmed cell death of human macrophages infected with Mycobacterium avium
8. The C-D interhelical domain of the serpin plasminogen activator inhibitor type-2 is required for protection from TNF-alpha induced apoptosis
9. Monocyte plasminogen activator inhibitor 2 (PAI-2) inhibits u-PA-mediated fibrin clot lysis and is cross-linked to fibrin
10. Type-2 plasminogen activator inhibitor is a substrate for trophoblast transglutaminase and factor XIIIa-transglutaminase-catalyzed cross-linking to cellular and extracellular structures
11. Transglutaminases: Protein cross-linking enzymes in tissues and body fluids
12. Properties of the caspases
13. An induced proximity model for caspase-8 activation
14. Caspase-9 can be activated without proteolytic processing
15. Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme
16. Cytokine response modifier A (CrmA): A strategically deployed viral weapon
17. Inhibition of interleukin-1β converting enzyme by the cowpox virus serpin CrmA: An example of cross-class inhibition
18. Protein synthesis is required for caspase activation and induction of apoptosis by bisphosphonate drugs
19. Immunohistochemical demonstration of the plasminogen activator system in human gingival tissues and gingival fibroblasts
20. The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival
21. Spontaneous human monocyte apoptosis utilizes a caspase-3-dependent pathway that is blocked by endotoxin and is independent of caspase-1
22. Pro-caspase-3 is a major physiologic target of caspase-8
23. FLICE induced apoptosis in a cell-free system
24. Fas mediates apoptosis in human monocytes by a reactive oxygen intermediate dependent pathway
25. Signaling to p53: Breaking the MDM2-p53 circuit
26. Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis
27. Bax membrane insertion during Fas (CD95)-induced apoptosis precedes cytochrome c release and is inhibited by Bcl-2
28. Lipopoly-saccharide, tumor necrosis factor-α and IL-1β prevent programmed cell death (apoptosis) in human peripheral blood monocytes
29. Activation of human monocytes induces differential resistance to apoptosis with rapid down regulation of caspase-8/FLICE
30. The Bcl-2 protein family: Arbiters of cell survival
31. Cleaved intracellular plasminogen activator inhibitor 2 in human myeloleukaemia cells is a marker of apoptosis
32. Expression of plasminogen activator inhibitor 2 in normal and psoriatic epidermis
33. Plasminogen activator inhibitor type 2: An intracellular keratinocyte differentiation product that is incorporated into the cornified envelope
34. Evidence for intracellular cleavage of plasminogen activator inhibitor type 2 (PAI-2) in normal epidermal keratinocytes
35. The serine proteinase inhibitor (serpin) plasminogen activator inhibitor type 2 protects against viral cytopathic effects by constitutive interferon α/β priming
36. Picornavirus receptor down-regulation by plasminogen activator inhibitor type 2
37. Plasminogen activator inhibitor type-2 is a major protein induced in human fibroblasts and SK-MEL-109 melanoma cells by tumor necrosis factor
38. Cytokine regulation of the synthesis of plasminogen-activator inhibitor-2 by human vascular endothelial cells - Comparison with plasminogen-activator inhibitor-1 synthesis
39. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation
40. Thrombin as a multifunctional protein: Induction of cell adhesion and proliferation
41. Thrombin promotes activation of metalloproteinase-2 produced by cultured vascular smooth muscle cells
42. Binding of thrombin to subendothelial extracellular matrix